NPY2R
MOLECULAR TARGETneuropeptide Y receptor Y2
NPY2R (neuropeptide Y receptor Y2) is targeted by 16 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting NPY2R
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | Peptide YY | 1.61 | 4 |
| 2 | neuropeptide y | 1.61 | 4 |
| 3 | Carvedilol | 1.10 | 2 |
| 4 | Hexachlorophene | 1.10 | 2 |
| 5 | paxilline | 1.10 | 2 |
| 6 | 2-Chloroadenosine 2-Chloroadenosine. | 0.69 | 1 |
| 7 | Cilostazol | 0.69 | 1 |
| 8 | Digitoxin | 0.69 | 1 |
| 9 | Digoxin | 0.69 | 1 |
| 10 | Diphenhydramine | 0.69 | 1 |
| 11 | Metergoline | 0.69 | 1 |
| 12 | Misoprostol | 0.69 | 1 |
| 13 | Nadolol | 0.69 | 1 |
| 14 | Ouabain | 0.69 | 1 |
| 15 | Pindolol | 0.69 | 1 |
| 16 | Propafenone | 0.69 | 1 |
About NPY2R as a Drug Target
NPY2R (neuropeptide Y receptor Y2) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 16 compounds with documented NPY2R interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
NPY2R inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.